Evidence map›Paper›PMID 40660992›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2025

[Research progress on the diagnostic performance and predictive accuracy of different prognostic scores as non-invasive liver fibrosis models for primary biliary cholangitis].

J Feng, Y T Li, J M Xu, J Y Zhang, S M Li, Y M Tang

Abstract readReviewEnglish Abstract
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J FengDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical Univercity, Kunming 650000, China.
Y T LiDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical Univercity, Kunming 650000, China.
J M XuDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical Univercity, Kunming 650000, China.
J Y ZhangDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical Univercity, Kunming 650000, China.
S M LiDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical Univercity, Kunming 650000, China.
Y M TangDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical Univercity, Kunming 650000, China.

Funding

Clinical Research Project of the Second Affiliated Hospital of Kunming Medical University 2020ynlc010, ynlIT2021017Medicine Leading Talents of Yunnan Province L-2019013
6 · The paper itself

Abstract

The grade of histological severity is a determining factor to evaluate the prognosis and survival rate in primary biliary cholangitis (PBC). However, liver biopsy is limited by sampling error, invasiveness, high cost, and poor compliance. Therefore, in order to overcome the limitations of liver biopsy, some non-invasive evaluation methods have been studied and applied to evaluate the progression of liver fibrosis in PBC. The prognostic score can be calculated using routine laboratory test results obtained at the time of diagnosis, which are characterized by their simplicity, affordability, ease of acquisition, and superior reproducibility. Recent studies have reported that the prognostic score can be employed as a non-invasive liver fibrosis model to diagnose the liver fibrosis stage in PBC and predict the transplant-free survival rate, in addition to being used to evaluate the patient prognosis and transplant-free survival (TFS). This paper reviews, summarizes, and explores the research progress of different prognostic scores as non-invasive liver fibrosis models via their diagnostic performance and predictive accuracy for PBC.

Indexed as

Liver CirrhosisLiver Cirrhosis, BiliaryBiopsyHumansLiverPrognosisSurvival Rate

Identifiers

PMID40660992
PMCPMC12861842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.